跳至主要内容
临床试验/CTRI/2024/02/063349
CTRI/2024/02/063349尚未招募4 期

A Randomized Comparative Study to Evaluate The Effects and Safety of Intrathecal Hyperbaric Levobupivacaine 0.5% and Hyperbaric Ropivacaine 0.75% In Patients Undergoing Transurethral Resection of Prostate(TURP) Surgery under Spinal Anaesthesia

Karan Malhotra1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年3月1日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
The objective of the study is to evaluate the efficacy in terms of onset and duration of sensory block as primary outcome in two groups: Group 1(L) – 3ml 0.5% hyperbaric levobupivacaine and Group 2(R) – 3ml 0.75% hyperbaric ropivacaine.

研究概览

简要总结

The present prospective, randomized and double blind study will be conducted in Department of Anaesthesiology, MMIMSR Mullana Ambala, Haryana. After the approval of protocol by the Institutional Ethics Committee, and registration with Clinical Trial Registry India, a total number of 50 ASA I and ASA II status patients scheduled for elective TURP surgery under spinal anaesthesia will be included in the study after obtaining informed consent for the study. The effects and efficacy of hyperbaric LEVOBUPIVACAINE 0.5% and hyperbaric ROPIVACAINE 0.75% will be compared.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant and Investigator Blinded

入排标准

年龄范围
0.00 Year(s) 至 99.00 Year(s)(—)
性别
Male

入选标准

  • ASA 1 and ASA 2 patients posted for TURP.

排除标准

  • Negative consent by the patient
  • Contraindication for spinal Anaesthesia (such as coagulopathy, infection at injection site, hypotension, disease or deformity of spine)
  • Psychiatric patient
  • ASA status III/IV
  • Known sensitivity to the drug.

结局指标

主要结局

The objective of the study is to evaluate the efficacy in terms of onset and duration of sensory block as primary outcome in two groups: Group 1(L) – 3ml 0.5% hyperbaric levobupivacaine and Group 2(R) – 3ml 0.75% hyperbaric ropivacaine.

时间窗: Outcomes will be assessed at baseline, time intervals of 2min upto 10min after administration of spinal anaesthesia with the selected drugs followed by every 5 minutes until completion of surgery

次要结局

未报告次要终点

研究者

发起方
Karan Malhotra
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Karan Malhotra

MMIMSR, Mullana

研究点 (1)

Loading locations...

相似试验

Randomized comparative study to evaluate safety of... | 临床试验